The U.S. market for OTCs has shown a compound annual growth rate of only 2.6% from 2011 through 2016. Most years during that five-year period the market have shown 3.0% or less year-over-year growth, with the exception of 2014 to 2015, when the market was up nearly 5.0%. This was largely driven by the return to market of previously recalled brands. By comparison, natural OTCs (which refers to non-drug, non-monograph, plant- or supplement-based, or homeopathic products that often make claims of support, prevention, maintenance, and/or treatment of minor conditions or ailments) have grown strongly by double digit gains over the same timeframe.Continue reading
Strengthening FDA’s labeling requirements for the non-drug market, new and innovative product developments, aggressive acquisition strategies by large multinationals, and changes in consumer preferences towards specific ingredients reshape the U.S. natural OTC market in 2015.
During this live webinar, Laura Mahecha, Kline’s Healthcare Industry Manager, will reveal some interesting key findings from our recently published Natural OTCs: Impact of Non-drug Products on the U.S. OTC Market report. The session will take place on Thursday, July 21, 2016 at 11:00 AM EDT | 17:00 PM CET.Continue reading